COR
Cencora, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 28 ▲ Four major institutions, including Fidelity and sovereign wealth fun…
- Mar 23 to Mar 31 ▲ 2 buys: Jared Moskowitz bought $1,001 - $15,000, last disclosed May 1
- May 28 ▲ 1 insider buy $1.1M at $266.26
- Jun 18 to Jun 22 ▲ 2 days of insider buys: $1.2M by 2 insiders, avg $273.71
- Jun 30 ▲ 4 funds open new positions (13F)
- Aug 19 RBC Capital initiates
- Aug 24 ▼ 1 insider sell $3.7M at $324.12
- Sep 1 ▼ 1 insider sell $321.1K at $325.97
- Sep 16 ▼ 1 insider sell $411.3K at $321.30
- Oct 1 ▼ 1 insider sell $298.9K at $303.18
- Nov 2 ▼ 1 insider sell $326.3K at $330.96
- Nov 4 ▲ Earnings: COR Q4 2026 Earnings: EPS $4.66 (+0.7% vs est)
Signal stack
Where each data set points today.
- InsidersBEARISH
2 insiders bought $2.3M at an average $270.23. 3 insiders sold $5.0M. Price is 32% above their cost.
- InstitutionsMIXED
Q2 2026: 61 added (4 new), 53 trimmed or exited. Largest new: Vanguard Capital Management $3.5B, Marshall Wace $96.8M.
- AnalystsBULLISH
14 of 20 rate it Buy or better. Median target $387.50 (+9%).
- Short sellersCOVERING
Short interest −19.8% to 3.16M shares. 2.6 days to cover, ≈1.6% of shares.
- TrendUPTREND
9% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | NEW | $3.5B |
| FMR LLC | TRIM | $1.2B |
| Amundi | ADD | $630.9M |
| Mitsubishi UFJ Asset Management Co., Ltd. | ADD | $483.8M |
| Mawer Investment Management Ltd. | ADD | $421.3M |
| CITADEL ADVISORS LLC | ADD | $386.7M |
| AMERICAN CENTURY COMPANIES INC | ADD | $338.7M |
| Neuberger Berman Group LLC | ADD | $332.2M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
20 analystsPrice is inside the target range. Median implies +9%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 10, 2026 | JP Morgan MAINTAIN | Overweight |
| Nov 5, 2026 | Leerink Partners MAINTAIN | Outperform |
| Nov 5, 2026 | Evercore ISI Group MAINTAIN | Outperform |
| Oct 30, 2026 | Morgan Stanley MAINTAIN | Overweight |
| Oct 22, 2026 | Baird MAINTAIN | Outperform |
| Oct 20, 2026 | Argus Research MAINTAIN | Buy |
Washington
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Campbell Elizabeth S Executive Vice President Nov 12, 2026 | EXERCISE | 1,174 sh |
Krikorian Lazarus SVP & Chief Accounting Officer Nov 12, 2026 | TAX W/H | $95.7K |
Mauch Robert P. President & CEO Nov 12, 2026 | TAX W/H | $673.3K |
Verma Pawan EVP, Chief Data & Info Officer Nov 12, 2026 | TAX W/H | $236.2K |
Krikorian Lazarus SVP & Chief Accounting Officer Nov 12, 2026 | EXERCISE | 666 sh |
Mauch Robert P. President & CEO Nov 12, 2026 | EXERCISE | 4,682 sh |
Campbell Elizabeth S Executive Vice President Nov 12, 2026 | TAX W/H | $189.7K |
Verma Pawan EVP, Chief Data & Info Officer Nov 12, 2026 | EXERCISE | 1,321 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
12 filings · 4 bullish · 0 bearish · 2 mixed · 6 neutral- NEUTRAL 8-KNov 4, 2026
Cencora filed an 8-K to disclose a restructuring of its operating model and a new reportable…
Monitor the Q1 FY2027 earnings release for the first full-quarter results under the new segment structure and for any updates on the strategic alternatives for the Other segment businesses.
- BULLISH 8-KNov 4, 2026
Cencora reported fiscal Q4 2026 adjusted EPS of $4.66, beating the $4.57 consensus by 2.0%, on…
The beat-and-raise quarter combined with the AON acquisition and new segment structure signals accelerating specialty pharma momentum. Watch for integration updates on AON and the Profarma sale…
- BULLISH 8-KOct 21, 2026
Cencora announced a definitive agreement to acquire American Oncology Network (AON) for a $2.4…
Monitor regulatory clearance timeline and AON stockholder vote for closing conditions. The November 4 earnings call will provide fiscal 2027 guidance, which should clarify the accretion trajectory…
- MIXED INST-CLUSTEROct 20, 2026
Institutional activity in Cencora (COR) during Q3 2026 was mixed: three asset managers added…
The cluster is evenly split in conviction, but the selling side is larger in absolute dollars. Monitor upcoming 13F filings for Q4 to see if the selling trend continues or if buyers re-emerge. No…
All COR filing & press-release reports (12)
- 8-K reportNov 4, 2026
- 8-K reportNov 4, 2026
- 8-K reportOct 21, 2026
- INST-CLUSTER reportOct 20, 2026
- 8-K reportSep 25, 2026
- INST-CLUSTER reportAug 21, 2026
- 8-K reportAug 5, 2026
- 8-K reportAug 5, 2026
- 8-K reportJun 15, 2026
- 8-K reportMay 29, 2026
- 8-K reportMay 6, 2026
- INST-CLUSTER reportFeb 28, 2026